oral glp-1 agonist approved Lilly is now pharma's top revenue company. It just got FDA approval for an GLP-1, but Wall Street isn't celebrating Daily Oral GLP-1 Receptor Agonist

A double-blind, randomized, controlled phase III trial of afamelanotide (an alpha-MSH analogue) in erythropoietic protoporphyria (EPP): preliminary data on a Swiss cohort of patients and a model to determine efficacy in EPP [abstract]

Doctors rely on patient-reported information, supported by their clinical judgement, to make a prescribing decision, it said, further stressing that patient safety and regulatory compliance are foundational to how Apollo 24|7 operates

Total Wellness: It is not just the IV antioxidant injection that will help you look better, but a healthy diet and the use of sunblocks as well

In an animal study using 5-dihydrotestosterone + insulin treatment to simulate a miscarriage model in PCOS patients, NAC supplementation improved fetal survival rates in model mice by protecting mitochondrial function, restoring the balance of SOD1 and the Keap1/Nrf2 antioxidant response, reducing excessive ROS production, and mitigating placental formation defects [57]